Background. The age-associated impairment in left ventricular (LV) systolic function appears to be mostly detectable during exercise or sympathetic stimulation. We hypothesized that the decline in cardiac function could be unmasked by an acute increase in afterload induced by phenylephrine. We further sought to examine whether the deterioration in cardiac function is influenced by gender.
C
ARDIOVASCULAR function decreases progressively with advancing age (1) (2) (3) (4) and is generally manifested as impaired myocardial contraction and relaxation, increased arterial stiffness, and diminished inotropic and chronotropic responses to catecholamines (1, 2, 4) . In humans, the impaired left ventricular relaxation and diastolic function can generally be detected both at rest and during exercise, and is reflected in diminished left ventricular filling in older subjects (5) . In contrast, the age-associated decline in systolic function appears to be mostly detectable during exercise or sympathetic stimulation (4, 6) . Previous data suggest that resting left ventricular ejection fraction remains normal in older subjects and is similar to that generally seen in younger subjects (7) . Therefore, it appears that in order to assess the effect of aging on left ventricular systolic function in humans, it is necessary to use some form of stress to bring about any detectable aging-related effect. In this study, we used phenylephrine to evaluate the effects of aging and gender on left ventricular systolic function. Phenylephrine is a potent ex-adrenergic agonist that is effective in acutely increasing afterload. We hypothesized that the age-associated decline in left ventricular systolic function can be unmasked by an acute increase in afterload induced by graded doses of phenylephrine. We further sought to determine whether the age-associated deterioration in cardiac function can be influenced by gender, as previous studies have shown that gender can play a role not only in cardiac responses to acute exercise but also in cardiovascular adaptations to endurance exercise training (8) (9) (10) .
METHODS

Subjects.-Seventeen young (20-31 years old) and 21
older (60-75 years old) individuals participated in this study. There were 8 men and 9 women in the young group, and 10 men and 11 women in the older group. The ages of the older men and women were 66.4 ± 1.7 years and 64.4 ± 1.0 years, respectively; the young men and women were 24.5 ± 1.1 years and 25.1 ± 1.1 years, respectively. The subject characteristics for each group are summarized in Table  1 . All participants were sedentary nonsmokers, and the older subjects were carefully screened for the presence of coronary risk factors and coronary artery disease. All subjects were healthy, asymptomatic, and had normal cardiac examinations; none was taking cardiovascular medications. None of the older women was on hormone replacement therapy. The exclusion criteria were: history of known coronary artery or other cardiac diseases, hypertension, significant elevation of plasma cholesterol (>220 mg/dl), an abnormal glucose tolerance test, exercise-indexed myocar-M18 TURNER ETAL. sion and/or exercise-induced myocardial perfusion defect. All subjects signed an informed written consent, and the study protocol was approved by the Human Studies Committee of the Washington University School of Medicine.
Exercise tests and measurement ofmaximal oxygen uptake (V02max).-Initially, each older subject underwent a graded treadmill exercise test using the Bruce protocol (11). Two weeks later, the subjects performed a maximal treadmill test to determine VOzmax, as previously described (12) . VOz was measured continuously by open-circuit spirometry previously validated against the Douglas bag technique (12) . Inspiratory volume was measured with a Parkinson CD-4 dry gas meter. O, and COz were sampled from a mixing chamber and their fractional concentrations quantified using electronic O, (Applied Electrochemistry S3-A, Sunnyvale, CA) and COz (Beckman LB-2, Fullerton, CA) analyzers. VOzmax was defined as the mean of the two highest consecutive 30 s O, measurements that met at least two of the following criteria: (a) attainment of a plateau of O, with increasing exercise intensity, (b) HR ± 10 b/min of the age-predicted maximal HR, and (c) a respiratory exchange ratio >1.10.
Left ventricular size and systolic perJormance.-Left ventricular (LV) size and systolic function were assessed with the use of two-dimensional echocardiography including 2D-guided M-mode images with a 2.5 mHz transducer (Hewlett-Packard Model 2000, Andover, MA). Images were obtained in the supine position using the standard views according to the guidelines recommended by the American Society of Echocardiography (13) . The end-diastolic dimension (EDD) and end-systolic dimension (ESD) were measured using standard guidelines (13) . Left ventricular mass (LVmass) was estimated using standard equations (14) . Fractional shortening (FS) was calculated as FS = 100(EDD -ESD)/EDD. Left ventricular end-systolic wall stress (rres) was estimated as described by Grossman et al. (15) : oes = Prl2h(1+[h/2r]), where P is systolic blood pressure (SBP) expressed as g/cm', r is end-systolic radius (ESDI2), and h is end-systolic posterior wall thickness. Left ventricular contractile performance was assessed using (a) the FS-ues relationship by plotting FS as a function of rres and (b) the cres-ESD relationship by plotting cr. s as a function of ESD during graded doses of phenylephrine infusion and cardiac muscarnic receptor blockade (atropine), taking into account the changes in EDD, as an index of preload, and heart rate. The reproducibility of these measurements has been reported from our laboratory (16) . Statistics.-The differences in variables between age groups and genders were compared with the use of a twoway analysis of variance (ANOVA). To assess the differences in physiological responses to phenylephrine, the data were analyzed across the infusion doses with the use of an ANOVA with repeated measures to compare the effects of age, gender, and the interaction between age and gender. An analysis of covariance with repeated measures was utilized if differences existed between groups prior to the phenylephrine infusion. Data are given as means ± SE.
RESULTS
Subject Characteristics
The subject characteristics are summarized in Table 1 . The men were heavier and taller compared to the women, regardless of age (p < .05). Body surface area (BSA) was larger in the men than in the women, regardless of age. There were both age and gender effects for V02max. The young men had the highest and the older women had the lowest V02max. The decrease in V02max observed in the older subjects was in part attributable to a slower maximal heart rate (HRmax) compared to the young subjects (Table 1) .
Baseline Hemodynamics and Left Ventricular Size and Function
wall thickness, and ESD indexed for BSA were not different between the men and women. Baseline FS ( Figure 3A) was significantly higher in the women than in the men (p < .05). Baseline HR, SBP, DBP ( Figure 1 ), and <res ( Figure  3B ) did not differ between the men and women. Left ventricular wall thickness-to-radius (hlr) ratio and LV mass index were not different between the men and women (Table 1) . (Table  2) or relative to BSA, were not different between the older and younger subjects. However, the end-systolic wall thickness was significantly dfferent among the groups except for the young men and older women whose differences were not significant ( Figure 2 ). It was the largest in the older men and smallest in the younger women ( Figure 2 ). LV fractional shortening (FS), end-systolic wall stress (<res), and left ventricular wall thickness-to-radius (hlr) ratio were also not different between age groups (Table 2) . LV mass normalized for BSA was larger in the older compared to the younger subjects (Table 1) .
Gender effects.-EDD normalized for BSA was larger in the women (p < .05). LV posterior wall thickness, septal Age X Gender interaction effects.-There were no significant Age X Gender interaction effects for any of the baseline measures.
Cardiac Responses Following Vagal Blockade
Age effects.-There was no effect of age on the changes from baseline in EDD, ESD, HR, SBP, and DBP after vagal blockade ( Table 2) . Fractional shortening increased slightly in the older subjects (0.23 ± 1.01 and 1.66 ± 1.45, women and men, respectively) but decreased in the younger subjects (-2.01 ± 0.75 and -1.19 ± 0.55, women and men, respectively) in response to atropine ( Figure 3A) . The changes in <res induced by atropine were different in the two age groups, decreasing in the older (-1.52 ± 3.98 and -3.02 ± 2.50, women and men, respectively) and increasing in the younger subjects (6.35 ± 1.87 and 3.57 ± 2.47, women and men, respectively). The different responses in <res probably account for the age-related differences in FS. 
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Gender effects.-The changes in EDD, ESD, FS, <res, SBP, and DBP from baseline in response to vagal blockade were not different between the men and women ( Figure 1 . A Mean heart rates (± SE) and B mean systolic and diastolic blood pressure (± SE) at baseline, after atropine, and during infusion of .25, .50, .75, and 1.00 /lg-kg-1-min-1 of phenylephrine in young and older men and women. *Denotes difference between age groups; [denotes difference between genders; and :j:denotes interaction between age groups and genders. OM indicates older men; OW, older women; YM, young men; YW, young women; Atr, atropine. Figure 2 . Effect of age on left ventricular (LV) end-systolic wall thickness at baseline, after atropine, and during infusion of phenylephrine. LV wall thickness was greater in the older than younger subjects (p < .05) and decreased to a much lesser extent in the former than the latter groups (p < .05). The attenuated rise in LV end-systolic wall stress in the older subjects was due, in part, to the differences in LV wall thickness between the younger and older subjects. Cant. =control; at. = atrophine. Age effects.-EDD and ESD increased to similar extents in response to phenylephrine ( Table 2 ,'p < .001) in the young and older subjects. LV fractional shortening decreased in all subjects (Table 2, p < .001); with the young and older subjects responding in a similar manner. Endsystolic wall stress increased in response to phenylephrine (Table 2, p < .001) in all groups, but there was a greater increase in (Jes in the young subjects (p < .01) compared to the older subjects. The left ventricular end-systolic wall thickness decreased in all groups. However, the decrease was significantly greater in the young men and women than in the older subjects (Figure 2) , accounting for the smaller increase in (Jes in the older subjects. The FS-(Jes relationship (Figures 4 and 5) was linear for both older men and women (r = -.943 ± .021 and -.919 ± .018, respectively) and young men and women (r =-.908 ± .028 and -.896 ± .033, respectively). The young men and women exhibited a markedly less steep slope for the FS-(Jes relationship (-.06 ± .01 and -.05 ± .01, respectively) compared to the older men and women (-.19 ± .04 and -.16 ± .03, respectively). The (Jes-ESD relationship ( Figure 4B ) was also linear for both older men and women (r = .915 ± .017 and .897 ± .022, respectively) and young men and women (r = .907 ± .035 and .913 ± .026, respectively). The young men and women showed a steeper slope for the (Jes-ESD relationship (16.71 ± 4.52 and 13.79 ± 1.75, respectively) compared to the older men and women (8.03 ± 1.77 and 8.50 ± 2.08, respectively). Therefore, the older subjects exhibited a significantly greater decline in LV systolic shortening in response to a given increase in (Jes induced by phenylephrine when compared to young subjects ( Figure 5 ). The HR responses to phenylephrine were different between the young and older subjects ( Figure 1A) , with the young subjects showing an increase but the older subjects showing a decrease in the HR responses even though the doses of atropine normalized for body weight were similar in older and younger subjects (14.3 ± 0.1 and 14.7 ± 0.1 ug/kg, respectively; p = .66). There were similar increases in SBP in response to phenylephrine in the older and younger subjects ( Figure  1B) . Diastolic blood pressure also increased progressively with phenylephrine in all groups ( Figure 1B, p < .001) . The magnitude of the increase in DBP, however, was greater (p < .01) in the young subjects than in the older subjects.
.
Gender effects.-There were no gender-related differences in the EDD, FS, (Jes, HR, SBP, and DBP responses to phenylephrine (Table 2) . However, the increase in ESD was greater in the men than in the women ( Table 2 ). The slopes of the FS-(Jes relationship and the (Jes-ESD relationship were not different between the genders (p > .05).
Age X Gender interaction effects.-There were no Age X Gender interaction effects in the EDD, ESD, FS, (Jes, HR, and DBP responses to phenylephrine (Table 2 ). There were no Age X Gender interaction effects on the slopes of the FS-(Jes relationship and the (Jes-ESD relationship. The increase in SBP to phenylephrine ( Figure 1B) was signficantly different, as the young men and older women exhibited greater SBP responses compared to the older men and young women at the two highest doses of phenylephrine. Figure 3 . A Mean fractional shortening (± SE) and B mean end-systolic wall stress (± SE) at baseline, after atropine, and during infusion of .25, .50, .75, and 1.00~g·kg-I·min-l of phenylephrine in young and older men and women. *Denotes difference between age groups; tdenores difference between genders. OM indicates older men; OW, older women; YM, young men; YW, young women; Atr, atropine.
Age X Gender interaction effects.-There were no Age X Gender interaction effects in any of the variables in response to vagal blockade. blockade, however, was greater in the women than in the men, probably because of a greater degree of vagal blockade ( Figure 1A ). The increase in HR from rest to vagal blockade for all subjects was not correlated to body weight (r =.193,p > .05).
Effects of atropine dosage.-There was no aging effect on the dose of atropine normalized for body weight, with no statistically significant differences between the older and younger men and women. However, we found a genderrelated difference in the relative dose -of atropine with women, young and old alike, receiving a larger dose (p < .05) than the men (young women: 16.3 ± 0.7 meg/kg, young men: 13.0 ± 0.7 meg/kg, older women: 16.2 ± 0.6 meg/kg, and older men: 12.4± 0.66 meg/kg). There was no Age X Gender interaction attributable to atropine.
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DISCUSSION
The purpose of this study was to determine whether the phenylephrine-stimulated increase in afterload is useful in identifying the effects of age and gender on left ventricular systolic function. To assess the cardiac effects attributable to aging alone, all older subjects were rigorously screened for the presence of coronary risk factors and myocardial ischemia. Our findings suggest that age can significantly influence the cardiovascular responses to a-adrenergic stimulation and that phenylephrine, by acutely increasing afterload, is effective in ummasking the age-associated deterioration in left ventricular systolic function. This is evidenced by a steeper slope of the FS-<Tes relationship in older subjects, showing a greater decrease in FS in response to a given increase in (J'es, and a less steep slope of the (J'es-ESD relationship in older subjects who exhibited a smaller increase in (J' es in response to a given increase in ESD compared with young subjects. The differences in the slope of the FS-(J'es relationship between the young and older subjects can reflect an age-related decrease in contractile reserve or the differences in the use of the preload reserve, with the younger subjects having the ability to utilize the preload reserve more effectively than the older subjects, therefore preventing the excessive fall in FS in response to an acute increase in left ventricular wall stress (17) . However, the role of preload in modulating these changes appears unlikely, because the similarity of the EDD responses to phenylephrine, used as an index of preload, in the older and younger subjects argues against this possibility. The FS-(J'es and (J'ecESD relationships are reliable measures of LV contractile function provided that preload does not change significantly.
The greater left ventricular end-systolic wall thickness in the older subjects, which did not decrease in response to phenylephrine, was most likely responsible for the blunted increase in (J' es, particularly in the older women. This adaptive response provides a useful mechanism to prevent an excessive fall in left ventricular systolic shortening in response to an acute afterload challenge and can, therefore, conceal the age-related decline in LV contractile reserve in the older healthy subjects .
In vitro studies (18, 19) using phenylephrine with isolated ventricular preparations have demonstrated a decline in inotropic responsiveness to phenylephrine with age in rats and humans. Phenylephrine is a potent o-adrenoreceptor agonist (20) . Although it has some l3-adrenergic property, this effect, compared to a-adrenergic activity, is small (21) . A positive inotropic effect with u.-adrenergic stimulation has been shown with phenylephrine (22) in the intact human heart. This positive inotropic effect, however, is not as profound as that observed with l3-adrenergic stimulation and accounts for only a small fraction of the increase in contractility compared with l3-adrenergic simulation (approximately 8-10% of the 131-mediated response) (21) . This a-adrenergic-stimulated increase in contractile state is believed to be only a complementary response to the positive inotropic effect of l3-adrenergic stimulation (22) . The findings of our study do not distinguish the myocardial effects of phenylephrine (a and 13 stimulation) from those attributable to its vasoconstrictive property that can induce a significant increase in systolic loading and afterload. Therefore, it is possible that the observed age-associated decline in the systolic shortening in response to phenylephrine may be, in part, mediated by a reduction in the number of 0.,-or (3,-adrenoreceptors (18) in the signaling pathway in the senescent heart (23), making the left ventricular myocardium more vulnerable to an afterload stress in older subjects.
The observed paradoxical elevation in HR in the young subjects with increasing doses of phenylephrine is most likely a consequence of vagal blockade. The typical, chronotropic response to phenylephrine is generally a decrease in HR (24) (25) (26) in the absence of vagal blockade, and is due to activation of the baroreflex response. A recent study by Saitoh et al. (27) showed results similar to those observed in the current study. These investigators (27) studied the chronotropic response to phenylephrine after both vagal and (3-blockade in 44 individuals aged 14 to 75 years. They found an age-associated difference in HR response, with the young subjects showing a paradoxical increase in HR whereas the older subjects exhibited a decrease in HR in response to phenylephrine. We found a similar age-related difference in the HR responses to phenylephrine in this study even though we did not use (3-adrenergic blockade. Age-related differences in the chronotropic response to 0.-adrenergic stimulation have also been reported in the Purkinje fibers of canine hearts (28) where the smaller increase in the impulse frequency in the senescent heart was attributed to the development of an inhibitory response to o-adrenergic stimulation with cardiac and nerve growth. The positive chronotropic response in the younger subjects may have contributed to greater contractile reserve mediated by the force-frequency relationship.
Research in experimental animals (29, 30) has found an age-related decline in vasoconstrictive responsiveness to 0.-adrenergic stimulation. However, human studies have provided conflicting results showing a decrease (26) or an increase (31) in o-adrenergic-mediated vasoconstrictive responsiveness. Elliott et al. (26) reported an aging-related decline in the mean arterial blood pressure responsiveness to phenylephrine. Our finding of a diminished diastolic blood pressure response to o-adrenergic stimulation in older subjects is in accordance with that of Elliott et al., suggesting a decline in the o-adrenergic-mediated vasoconstrictor responsiveness with aging. Endurance exercise training may restore the age-related decline in the vasopressor responses to o-adrenergic stimulation (24) .
The limitations of the current study include a relatively small sample size, the failure to use (3-adrenergic blockade, and the differences in the amount of atropine used in the subjects. Although the men were larger than the women regardless of age, resulting in a smaller dosage of atropine relative to body weight used in the men than in the women, there were no gender-related differences in the cardiovascular responses to phenylephrine following vagal blockade.
In conclusion, our findings demonstrate an age-related decline in the LV contractile reserve which can be readily shown by an acute increase in systolic loading and afterload. This effect is associated with a blunted «-adrenergicmediated vasopressor response. Furthermore, it appears that after even a partial inhibition of the baroreflex, there is a paradoxical positive chronotropic response to an u.-adrenergic stimulation in young individuals, which is lost with increasing age.
